Dr. Leroy - Dr. Kerkhof SRL
Dr. Leroy - Dr. Kerkhof reported total assets of 131,856 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Mar 2026).
The score of Dr. Leroy - Dr. Kerkhof shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -99 % Total assets +154 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Leroy - Dr. Kerkhof's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Mar 2026
- Year ended 31 Dec 2024filed on 10 Apr 2025
- Year ended 31 Dec 2023filed on 02 May 2024
- Year ended 31 Dec 2022filed on 28 Jul 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Dr. Leroy - Dr. Kerkhof's financial analysis
- Solvency0.4%sector median: 72.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Leroy - Dr. Kerkhof
Dr. Leroy - Dr. Kerkhof's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0729.816.221
- VAT number
- BE0729816221
- Peppol
- Registered · 0208:0729816221 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Jul 2019
- Registered office
- 3001 Leuven
- Latest accounts
- 2025 · filed on 24 Mar 2026
- Activity
- General medical practice activities (NACE 86210)
Dr. Leroy - Dr. Kerkhof (SRL) has been based in Leuven since 2019, active in: general medical practice activities. For 2025, it reports a net profit of 32,617 € and equity of 500 €; its revenue is not published. Its solvency stands at 0.4%, below the median of its sector (72.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Leroy - Dr. Kerkhof
Companies in the same business, of comparable size and area, outside its group.
- Dokter Alexander Smets General medical practice activities Kampenhout · balance sheet 132,004 €
- Avanst General medical practice activities Bertem · balance sheet 124,678 €
- Dr. Jolien Wevers General medical practice activities Haacht · balance sheet 106,669 €
- Société Privée Médicale Saikali General medical practice activities Overijse · balance sheet 90,516 €
- Medinut General medical practice activities La Louvière · balance sheet 84,640 €
- Dr. Kremer – Dr. Lenaerts General medical practice activities Kortenberg · balance sheet 120,639 €
- Docteur Philippe Burette General medical practice activities Aywaille · balance sheet 198,699 €
- Feniks General medical practice activities Duffel · balance sheet 214,266 €
Frequently asked questions about Dr. Leroy - Dr. Kerkhof
What is the revenue of Dr. Leroy - Dr. Kerkhof?
Dr. Leroy - Dr. Kerkhof files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Leroy - Dr. Kerkhof?
In Belgium, the VAT number is the company number prefixed with BE: BE0729816221 for Dr. Leroy - Dr. Kerkhof, if the company is VAT-registered. Its company number (CBE) is 0729.816.221.
Where is the registered office of Dr. Leroy - Dr. Kerkhof?
According to the CBE register, the registered office of Dr. Leroy - Dr. Kerkhof is in 3001 Leuven.
What is the equity of Dr. Leroy - Dr. Kerkhof?
At the close of the 2025 financial year, the equity of Dr. Leroy - Dr. Kerkhof amounts to 500 €, a solvency of 0.4% of total assets.
Who manages Dr. Leroy - Dr. Kerkhof?
The register lists 2 active mandates at Dr. Leroy - Dr. Kerkhof. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Leroy - Dr. Kerkhof
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →